Valuation: Thor Medical

Market Cap 2.06B 221M 189M 177M 162M 305M 21.08B 310M 2.08B 816M 10.57B 828M 810M 34.96B P/E 2026 *
-40.9x
P/E 2027 * -52x
Enterprise Value 2.24B 240M 206M 192M 176M 332M 22.96B 337M 2.27B 889M 11.51B 902M 882M 38.07B EV / Sales 2026 *
45.8x
EV / Sales 2027 * 13.3x
Free-Float
59.77%
Yield 2026 *
-
Yield 2027 * -
1 day+4.55%
1 week-4.32%
Current month+3.28%
1 month+40.38%
3 months+35.45%
6 months+36.69%
Current year+13.90%
1 week 5.62
Extreme 5.62
6.27
1 month 4.25
Extreme 4.25
6.62
Current year 3.88
Extreme 3.88
6.62
1 year 2.59
Extreme 2.59
6.62
3 years 0.85
Extreme 0.85
6.62
5 years 0.85
Extreme 0.85
6.62
10 years 0.85
Extreme 0.85
6.62
Manager TitleAgeSince
Chief Executive Officer 41 01/08/2024
Director of Finance/CFO 37 01/07/2023
Chief Tech/Sci/R&D Officer - 01/06/2023
Director TitleAgeSince
Director/Board Member 67 28/06/2023
Chairman 59 -
Director/Board Member - 24/04/2025
Date Insider Type Main position Quantity % Market Cap.
6/26/25 A
Scatec Innovation AS
OthersCompany 31,577,399 10.0434%
6/18/25 A
Scatec Innovation AS
BuyCompany 3,000,000 0.9542%
5/2/25 A Fiscal year

Director

164,641 0.0524%
Change 5-day change 1-year change 3-year change Capi.($)
+4.37%-4.32%+131.33%+359.29% 221M
-1.90%+3.12%+81.70%+110.88% 72.21B
-0.32%+15.96%+55.33%+91.80% 63.98B
+1.71%-1.22%+2.71%+501.29% 28.53B
+3.63%+8.57%+62.12%+24.72% 25.07B
+21.96%+21.98%+1.54%+2.50% 28.42B
+0.19%+6.57%+39.81%-13.51% 20.04B
0.00%-2.78%+247.46%+423.83% 18.19B
+1.81%+1.43%+23.67%+527.06% 15.96B
+2.39%+7.96%+44.96%+157.77% 13.48B
Average +3.40%+4.16%+69.06%+218.56% 28.61B
Weighted average by Cap. +2.35%+6.68%+60.92%+164.04%

Financials

2026 *2027 *
Net sales 49M 5.25M 4.5M 4.2M 3.86M 7.25M 502M 7.37M 49.61M 19.42M 252M 19.71M 19.28M 832M 168M 17.99M 15.44M 14.41M 13.22M 24.87M 1.72B 25.28M 170M 66.6M 863M 67.57M 66.1M 2.85B
Net income -49M -5.25M -4.5M -4.2M -3.86M -7.25M -502M -7.37M -49.61M -19.42M -252M -19.71M -19.28M -832M -40M -4.28M -3.68M -3.43M -3.15M -5.92M -410M -6.02M -40.49M -15.86M -205M -16.09M -15.74M -679M
Net Debt 183M 19.6M 16.81M 15.7M 14.4M 27.09M 1.87B 27.53M 185M 72.55M 940M 73.6M 72M 3.11B 177M 18.96M 16.26M 15.19M 13.93M 26.2M 1.81B 26.63M 179M 70.17M 909M 71.19M 69.64M 3B
Logo Thor Medical
Thor Medical ASA, formerly Nordic Nanovector ASA, is a Norway-based biopharmaceutical company. The Company is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium. The Company is utilizing alpha-emitters in radiotherapy and cancer treatments using Pb-212, which can be produced from naturally occurring isotope Thorium-232 and Lead-212. The Company has developed a proprietary technology for the manufacturing of radionuclides, primarily alpha-particle emitters from natural resources. The high energy deposition and the short range of alpha particles make it possible to eradicate cancer cells while minimizing damage to nearby healthy cells
Employees
-
Date Price Change Volume
20/08/26 NOK 5.970 +4.37% 4,736,461
19/08/26 NOK 5.720 -0.17% 2,605,035
18/08/26 NOK 5.730 -1.38% 2,319,912
17/08/26 NOK 5.810 -3.97% 5,343,827
14/08/26 NOK 6.050 -3.20% 4,784,716
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
5.720NOK
Average target price
3.500NOK
Spread / Average Target
-38.81%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NANOV Stock